Cargando…
Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson’s disease
BACKGROUND: Even though recent research has achieved significant advancement in the development of therapeutic approaches for Wilson’s diseases (WD), the current treatment options available for WD are still limited, especially for WD patients with neurological symptoms. This study is intended to com...
Autores principales: | Zhang, Jing, Xiao, Lulu, Yang, Wenming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320536/ https://www.ncbi.nlm.nih.gov/pubmed/32593295 http://dx.doi.org/10.1186/s12883-020-01827-9 |
Ejemplares similares
-
Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson’s disease patients with penicillamine-induced allergy or early neurological deterioration
por: Zhu, Xiao-Qun, et al.
Publicado: (2020) -
Long-term effects of a combination of D-penicillamine and zinc salts in the treatment of Wilson’s disease in children
por: CHANG, HONG, et al.
Publicado: (2013) -
D-penicillamine in Wilson's disease; recognizing the transition from benefit to harm
por: Goh, Yihui, et al.
Publicado: (2021) -
Comparison of the Effectiveness and Safety of d-Penicillamine and Zinc Salt Treatment for Symptomatic Wilson Disease: A Systematic Review and Meta‐Analysis
por: Tang, Shan, et al.
Publicado: (2022) -
Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease
por: Grażyna, Gromadzka, et al.
Publicado: (2013)